PCSA
Processa Pharmaceuticals Inc

4,771
Mkt Cap
$5.04M
Volume
55,115.00
52W High
$19.63
52W Low
$2.05
PE Ratio
-0.07
PCSA Fundamentals
Price
$2.22
Prev Close
$2.29
Open
$2.22
50D MA
$3.78
Beta
0.79
Avg. Volume
84,439.90
EPS (Annual)
-$96.82
P/B
0.80
Rev/Employee
$0.00
$1.59
Loading...
Loading...
News
all
press releases
News Placeholder
PCSA Stock Soars on Upbeat Clinical Update From Breast Cancer Study
Processa Pharmaceuticals stock jumps 122% after a phase II update shows NGC-Cap delivers higher active metabolite exposure with comparable safety in breast cancer.
Zacks·2mo ago
News Placeholder
Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data?
Processa Pharmaceuticals' stock jumps after Phase 2 data show higher capecitabine exposure without added toxicity in metastatic breast cancer patients.read more...
Benzinga·2mo ago
News Placeholder
Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks Making The Biggest Moves Today
Oracle shares were down over 5% in Wednesday’s midday session after Blue Owl Capital reportedly withdrew from a $10 billion investment in the company’s new facility in Saline Township, Michigan.
Stocktwits·2mo ago
News Placeholder
Why Did Processa Pharmaceuticals Stock Surge 160% Today?
The company announced that early Phase 2 data showed that its NGC therapy increased cancer-fighting metabolites in patients with advanced breast cancer.
Stocktwits·2mo ago
<
...
1
>

Latest PCSA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.